Thanks to its unique and revolutionary platform, Bio-Sourcing has achieved a major breakthrough in the oral delivery of monoclonal antibodies and other biotherapeutics. Furthermore, Bio-Sourcing’s proprietary production technology enables low-CAPEX, low-COGS and a sustainable high scalability manufacturing. 

At the core of our innovation is the production of therapeutic antibodies in the milk of gene-edited goats, where they are associated to milk-derived exosomes—nature’s own delivery vehicles. These exosomes protect the biotherapeutic from degradation in the gastrointestinal tract and enable oral bioavailability, making truly oral monoclonal antibodies possible, for the first time.